AccuStem Sciences, Inc. (OTCPK: ACUT)
Health Care · Biotechnology · US
$0.16
-3.70% today · -92.4% 1Y
AccuStem Sciences, Inc. (OTCPK: ACUT) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.51M and employs 4 people.
Over the last twelve months the share price has lost 92.4%, trading between 0.15 and 2.25.
Tweenvest scores AccuStem Sciences, Inc. across four factors: quality 9/100. Its strongest factor is quality.
ACUT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.51M
- Revenue (TTM)
- $98.40K
- P/E
- —
- EPS
- -0.11
- Dividend yield
- —
- Beta (5Y)
- 1.91
- 52-week high
- $2.25
- 52-week low
- $0.15
- Avg volume (3M)
- —
- Shares outstanding
- 16.07M
- Employees
- 4
- Next earnings
- —
About AccuStem Sciences, Inc.
AccuStem Sciences, Inc. operates as a life science firm committed to improving the outlook for individuals battling cancer. Its primary innovation is the StemPrintER technology, an advanced multi-gene prognostic assay designed to predict the likelihood of recurrence for patients with Endocrine receptor-positive /HER2- breast cancer. The company also offers Spare, a related diagnostic tool that expands upon StemPrintER by incorporating two additional clinical markers. AccuStem Sciences, Inc. is based in New York, New York.
- ISIN
- US00444A1016
- Founded
- 2013
- Listed since
- Mar 3, 2022
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $464.58B | $262.90 | -1.09% |
| Amgen Inc.NasdaqGS: AMGN | $238.06B | $440.34 | -0.43% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $183.64B | $148.09 | -0.01% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.72B | $547.29 | -1.01% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $81.36B | $814.79 | -2.25% |
| argenx SEENXTBR: ARGX | $65.40B | €897.60 | +2.09% |
| Moderna, Inc.NasdaqGS: MRNA | $59.75B | $149.66 | -5.77% |
| CSL LimitedASX: CSL | $59.19B | AU$172.44 | -0.69% |
Figures last refreshed Aug 18, 2026.